Target intelligence / Profile preview

14-3-3 protein sigma (14-3-3σ)

Target
14-3-3σ
Molecular classification
Adapter/scaffold protein, Regulatory protein, Phosphoserine/phosphothreonine-binding protein, 14-3-3 protein family
01

Overview

14-3-3 protein sigma (SFN, also referred to as Stratifin) is a member of the highly conserved 14-3-3 protein family, which functions primarily as an adapter or scaffold protein capable of binding phosphorylated serine- or threonine-containing motifs on a wide array of client proteins. 14-3-3σ is especially recognized for its role in cell cycle arrest at the G2/M checkpoint in response to DNA damage, acting as a tumor suppressor in various epithelial tissues by sequestering key regulatory proteins in the cytoplasm and preventing aberrant mitotic entry. It also participates in the maintenance of desmosomal junctions in epithelial cells by capturing PKP3, and its loss or hypermethylation is frequently observed in a variety of carcinomas. Its involvement in numerous cellular signaling pathways underlies its potential as a therapeutic target and biomarker, but the functional redundancy and complexity within the 14-3-3 family present significant therapeutic challenges.

Other names
StratifinSFNHME1YWHAS14-3-3 sigma14-3-3σ
02

Mechanism of action

Modulates protein–protein interactions by binding to phosphorylated serine/threonine motifs on client proteins, influencing their stability, localization, and function. Functions as a scaffold, occluding or exposing interaction motifs to control downstream signaling. Regulates cytoplasmic sequestration of specific proteins (e.g., Cdc25C, PKP3), thereby modulating cell cycle and adhesion.

03

Biological functions

Cell cycle controlSignal transductionApoptosis regulationProtein traffickingCellular stress responseMaintenance of cell junctions in epithelial tissueTranscriptional regulation
04

Disease associations

Cancer (notably tumor suppression in epithelial cancers)Neurodegenerative disease (biomarker use)Other (broad involvement in cellular homeostasis)
05

Safety considerations

Broad cellular roles and isoform redundancy could lead to off-target effects for pan-14-3-3 modulatorsPotential for unwanted modulation of cell cycle, apoptosis, and cellular stress responsesTissue-specific functions may complicate clinical safety profiles
06

Interacting drugs

No approved direct drugs known to specifically and selectively target 14-3-3 sigma as of now; peptide inhibitors and small-molecule modulators are reported in research contexts.
07

Biomarkers

Elevated 14-3-3 protein (primarily other isoforms such as eta) in cerebrospinal fluid for neurodegenerative diseases (notably Creutzfeldt–Jakob disease)Loss of 14-3-3 sigma expression is a biomarker for certain epithelial cancers

Beyond the preview

Go deeper on 14-3-3 protein sigma (14-3-3σ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 14-3-3 protein sigma (14-3-3σ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call